Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx® for Hormone Receptor Positive Patients Undergoing Neoadjuvant Chemotherapy
Crossref DOI link: https://doi.org/10.1245/s10434-019-07555-w
Published Online: 2019-07-24
Published Print: 2019-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kantor, Olga
Barrera, Ermilo
Kopkash, Katherine
Pesce, Catherine
Winchester, David J.
Yao, Katharine
Text and Data Mining valid from 2019-07-24
Version of Record valid from 2019-07-24
Article History
Received: 22 April 2019
First Online: 24 July 2019